Cardano Risk Management B.V. Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cardano Risk Management B.V. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 248,114 shares of the healthcare conglomerate's stock after buying an additional 940 shares during the quarter. UnitedHealth Group accounts for about 2.6% of Cardano Risk Management B.V.'s holdings, making the stock its 14th biggest holding. Cardano Risk Management B.V.'s holdings in UnitedHealth Group were worth $145,067,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD grew its position in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate's stock worth $12,893,331,000 after acquiring an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock valued at $4,094,247,000 after buying an additional 35,533 shares during the period. International Assets Investment Management LLC grew its holdings in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock worth $1,920,039,000 after purchasing an additional 21,149 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of research firms have commented on UNH. UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th. Truist Financial reissued a "buy" rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Cantor Fitzgerald lifted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 16th. Finally, Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $615.53.

UnitedHealth Group Stock Down 0.2 %

Shares of NYSE UNH traded down $0.92 during trading on Friday, hitting $592.23. The stock had a trading volume of 3,423,919 shares, compared to its average volume of 3,119,612. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market capitalization of $545.02 billion, a PE ratio of 38.58, a PEG ratio of 1.74 and a beta of 0.58. The firm has a fifty day moving average of $582.84 and a two-hundred day moving average of $549.98. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the company posted $6.56 earnings per share. UnitedHealth Group's quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group's payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.